The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
A bipartisan group of state health policymakers from both the executive and legislative branches who are focused on improving population health.
Supporting networks of state officials, advocates, and others aiming to invest in and transform primary care.
Advancing state-based efforts to make health care more affordable for residents, employers, and states.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
A leadership development program for early and mid-career state government officials who are committed to improving the health of all people in their communities.
A leadership program for senior state government officials who are committed to improving population health.
The Fund focuses on creating an affordable health care system built on strong primary care and partnerships that improve health outcomes for all.
Improving state leaders ability to enact and implement evidence-based health policies.
Advancing policies that create a more prevention- and primary care-oriented health system.
Improving population health through policies that contain health care cost growth.
Our state health policy resources provide relevant data analysis and best practices.
The Fund publishes reports, issues briefs, and case studies on state health policy issues.
Short takes on health policy issues from Milbank staff and guest authors.
Insights from Milbank President Debra Lubar on state health policymaking.
Reported articles and Q&As on timely health policy issues, as well as foundation updates.
Upcoming and past Milbank Memorial Fund and Milbank Quarterly webinars featuring state health policymakers and researchers.
Updates and expert contact information for reporters.
The Milbank Memorial Fund is a private foundation that works to improve population health and health equity.
December 2013 (Volume 91)
Quarterly Article
Thomas J. Smith
Sep 14, 2026
Sep 9, 2026
Back to The Milbank Quarterly
Welcome to Lake Wobegon, where all the women are strong, all the men are good-looking, and all the children are above average. —Garrison Keillor
Having read the article by Wolf and Wolf in this issue of The Milbank Quarterly, the oncologist part of me asks, “Where’s the beef?” This is typical care: Mrs.Wolf, an eighty year-old former smoker but healthy woman, is found (serendipitously) to have a resectable lung cancer and is treated with a curative resection based on her physiological age rather than her chronological age, as suggested by most guidelines (Hurria 2013). Indeed, based on the evidence available when she was diagnosed (Henschke et al. 2006), screening is now recommended by the U.S. Preventive Health Services Task Force (Humphrey et al. 2013). Appropriately, Mrs. Wolf declined adjuvant chemotherapy, based on a somewhat informed choice. Then when her cancer recurred, she had a good response to chemotherapy, which lasted for at least four months. We have known for twenty years that compared with the best supportive care, chemotherapy gains the average person a few months of life and increases, from about 20 percent to about 50 percent, the chance of being alive one year later (ASCO 1997). The chemotherapy that Mrs.Wolf received, carboplatin and pemetrexed (Alimta R ), is as successful as any other (Incollingo 2013; Patel, Socinski, and Garon 2012), and she likely did not have any nausea or lose her hair. Her recurrence was treated with FDA-approved erlotinib (Tarceva R ) for second-line use in her type of lung cancer (NCI 2013). She got brain radiation and neck spine radiation, with fairly typical side effects. In addition, she was in the lucky 54 percent of cancer patients who actually used hospice and was with hospice for two months, many times the national average of eight days (Morden et al. 2012). She had a terrible last month with agitation, delirium, and increasing debility, which sounds like a nightmare, but cancer is a tough business, as is being eighty and having one’s brain filled with “mets” (i.e., metastases) and being radiated.
The full commentary is available below.
Author(s): Thomas J. Smith
Read on Wiley Online Library
Volume 91, Issue 4 (pages 729–737) DOI: 10.1111/1468-0009.12031 Published in 2013